바이오인

 

 

 

As part of the Lisbon Strategy for Growth and Jobs, realising the European Research Area (ERA) has become an integral component of the EU’s response to the challenges posed by globalisation. The goal is to create a true European Single Market for Research, where knowledge, researchers and technology can move across frontiers in the same way as goods, people, services and capital do. This is the Fifth Freedom; the freedom of movement of
knowledge to where it is best used and exploited.

This Fifth Freedom is indispensable if Europe is to become the world’s leading ‘knowledge economy’, where knowledge will help sustain prosperity and competitiveness and address the societal challenges that concern European citizens.

By bringing together the research community, industry and policy-makers, it promotes scientific excellence and addresses the fragmentation and duplication in European research that leads to wasted resources, ground lost to our global competitors and a sub-optimal impact on economic growth and job creation.

Making the ERA come true is now a unanimously agreed objective that features high on the political agenda.

In the science and research area, the overall achievements between 2004 and 2009 have been:

>successfully targeting funding to where it has greatest impact on EU competitiveness and scientific excellence, through efficient implementation of a new EU Seventh Research Framework Programme with more funding (up to ??54 billion over 7 years); and

>putting the ERA project at the centre of the policy agenda through a series of initiative designed to make tangible improvements in building the freedom of movement of knowledge.

Beyond these global achievements, some particular successes are worth mentioning:

>Establishing the ERC (European Research Council), which grants EU research support, beyond the traditional collaborative transnational research project on predetermined subjects, to a more innovative, science-driven ‘free’ research model. The ERC has been a great success ? the first call for grants, in 2007 attracted over 9,000 applications;

>Creating effective public ? private technology partnerships associating enterprises and public research organisations in key areas for industrial and technological research through several large Joint Technology Initiatives (JTIs). JTIs increase the scale and impact of research investment, ensure the coordination and integration of research in Europe and raise the technology content of industrial activity. Five JTIs have been launched in areas such as innovative medicines, the hydrogen economy and nanoelectronics;

 

>Taking targeted st >> eps towards a European Research Area and the better coordination of national and EU efforts, by launching initiatives to promote mobility of researchers, joint programming of public research, cross-border investment in large infrastructures and better exploitation of research results. Member States have adopted a joint vision for ERA in 2020 with the right conditions for governance for research and investment in R&D. Member States will report on their progress in investing in R&D through their respective National Reform Programmes;

>Improving the focus of thematically-oriented European research on societal and long-term business needs and maximising the European added value of our support; We have focussed even more intensively, through policy, innovation, organisation and funding on how we can better deal with the major societal issues, such as Alzheimer’s, energy security,
climate change or food security.

>Opening European research to the world by adopting a resolutely international dimension, both in the implementation of the Framework Programme and in partnership with Member States. Global challenges need global cooperation and the achievements over the last five years have encompassed new scientific and technological agreements with our neighbours,
both global and local.

>Raising the average level of research in Europe, through specific actions promoting the regional dimension of research and supporting the development of research capacities in the enlarged EU. 26 out of the 27 Member States now have set their own research intensity targets and R&D expenditure increased with growth in real terms in all Member States. The Lisbon Strategy for growth and jobs has also resulted in a higher proportion of the Regional Policy Funds being earmarked for R&D and innovation. The EIB and the EC have joined forces to develop a new funding instrument for the knowledge economy: the Risk Sharing Finance Facility, freeing up some ??10 billion for investments in research development and innovation.

>Rationalising and simplifying rules and practices for beneficiaries of FP7 and programme management and by using research money even better. Outsourcing of many management tasks to the Research Executive Agency will help the Commission to manage increasing budgets with existing human resources, while g more on policy development.

>Consolidating the Joint Research Centre, the EU’s own research centre, as a provider of robust, independent scientific and technical support for EU policies....계속